Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 415-070-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An in vitro or in chemico skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study (different from LLNA test) is available.
Test material
- Reference substance name:
- -
- EC Number:
- 415-070-1
- EC Name:
- -
- Molecular formula:
- C52H26CrN10Na5O22S4
- IUPAC Name:
- chromium(3+) pentasodium bis(6-[2-(2-hydroxynaphthalen-1-yl)diazen-1-yl]-2-[2-(3-nitro-2-oxido-5-sulfonatophenyl)diazen-1-yl]-3-sulfonatonaphthalen-1-olate)
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Remarks:
- SPF-Quality
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
-Source: BRL Ltd., Basel, Switzerland
-Age at study initiation: ~ 9 weeks
-Weight at study initiation: 353 - 490 g
-Housing: Group housing of 2 animals per labelled metal cage with wire-mesh floors and equipped with an automatic drinking system (ITL, Bergen, The Netherlands).
-Diet: Free access to standard guinea pig diet, including ascorbic acid (1600 mg/kg);
LC 23-B, pellet diameter 4tnm (Hope farms, Woerden, The Netherlands).
-Water: Free access to tap water, diluted with decalcified water.
-Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
-Temperature (°C): 21 °C
-Humidity (%): 55 %
-Air changes (per hr): 15 air changes per hour
-Photoperiod (hrs dark / hrs light): 12 hour cycle dark/light with a fluorescent light
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- water
- Concentration / amount:
- 0.5 % (w/w)
- Day(s)/duration:
- a single injection
- Route:
- intradermal
- Vehicle:
- other: 50:50 FCA distilled water
- Concentration / amount:
- 0 %
- Day(s)/duration:
- a single injection
- Route:
- intradermal
- Vehicle:
- other: 50:50 FCA distilled water
- Concentration / amount:
- 1 %
- Day(s)/duration:
- a single injection
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- water
- Concentration / amount:
- 25 %
- Day(s)/duration:
- 48 hours
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 0.05 ml of 50%, 25% and 10%
- Day(s)/duration:
- 24 hours
- No. of animals per dose:
- Preliminary study : 5 females
Experimental group : 20 females
Control group : 10 females - Details on study design:
- PRELIMINARY STUDY
INDUCTION EXPOSURE: INTRADERMAL INJECTIONS
-No. of exposures: four injections
-Test groups: one female guinea pig
-Control group: none
-Site: clipped shoulder regions.
-Concentrations: 0.5 % (w/w) in distilled water.
-Evaluation (hr after challenge): 24 and 48 hours
INDUCTION EXPOSURE: EPIDERMAL APPLICATION
-No. of exposures: one application
-Exposure period: 24 hours
-Test groups: one female guinea pig (the same animal of intradermal injection)
-Control group: none
-Site: shaved flank
-Protection site: Scotchpak-non-woven patch on Micropore tape (both 3M, St. Paul, USA) and held in place by Coban elastic bandage (3M, St. Paul, USA).
-Concentrations: 50% (w/w) test substance concentration in distilled water (0.5 ml) was applied epidermally
-Evaluation (hr after challenge): 24 and 48 hours
EPIDERMAL APPLICATIONS
-No. of exposures: one
-Exposure period: 24 hours
-Test groups: four female guinea pig
-Control group: none
-Site: shaved flank
-Protection site: Square chambers (v.d. Bend, Brielle, The Netherlands), mounted on Micropore tape (3M, St. Paul, USA) and held in place by Coban elastic bandage.
-Concentrations: Four concentrations of the test substance in distilled water (50 %, 25 %, 10 % and 5 % w/w, 0.05 ml each)
-Evaluation (hr after challenge): 24 and 48 hours
The erythema and oedema assessments were based on this scale:
-Erythema and eschar formation:
No erythema: 0
Slight erythema (barely perceptible): 1
Well-defined erythema: 2
Moderate erythema: 3
Severe erythema (beet redness) to slight eschar formation (injuries in depth): 4
-Oedema:
No oedema: 0
Slight oedema (barely perceptible): 1
Well-defined oedema (edges of area well-defined by definite raising): 2
Moderate oedema (raised approximately 1 mm): 3
Severe oedema (raised more than 1 mm and extending beyond the area of exposure): 4
MAIN STUDY
A1. INDUCTION EXPOSURE: INTRADERMAL INJECTIONS
-No. of exposures: hree pairs of injections (0.1 ml/site)
-Exposure period: single injection
-Test groups: 20 female guinea pigs
-Control group: 10 female gunea pigs
-Site: scapular region
-Frequency of applications: one application for each site
-Concentrations:
A) The test substance at a 0.5% (w/w) concentration in physiological saline.
B) Freunds' complete adjuvant 50:50 with water for injection (Ferensius AG, Bad Homburg, Germany).
C) The test substance, at twice the concentration used in (A), emulsified in a 50:50 mixture of Freunds' complete adjuvant (Difco,
Brunschwig, Amsterdam, The Netherlands).
A2. INDUCTION EXPOSURE: EPIDERMAL APPLICATION (after 7 days)
The clipped scapular area was rubbed with 10% sodium-dodecyl-sulfate (SDS, Boom, Meppel, The Netherlands) in petrolatum using a spatula.
This concentration of SDS enhances sensitisation by provoking a mild inflammatory reaction.
-No. of exposures: one application
-Test groups: 20 female guinea pigs
-Control group: 10 female gunea pigs
-Site: scapular area
-Protection site: Scotchpak-non-woven patch mounted on Micropore tape and secured with Coban elastic bandage.
-Frequency of applications: one application
-Duration: 48 hours
-Concentrations: 0.5 ml of a 25% (w/w) test substance concentration
B. CHALLENGE EXPOSURE (after 14 days)
-No. of exposures: three applications
-Exposure period: 24 hours (excepted for animal 288 that had removed dressing before the 24 hour application period)
-Test groups: 20 female guinea pigs
-Control group: 10 female gunea pigs
-Site: flank
-Protection site: Square chambers attached to Micropore tape and secured with Coban elastic bandage.
-Concentrations: 0.05 ml of 25%, 10% concentration and the vehicle and approx. 0.05 ml for 50%
-Evaluation (hr after challenge): 24 and 48 hours after removal of the dressings.
The sites after removal were assessed for redness and swelling 24 and 48 h after removal of the dressings, using this numerical grading system:
no skin reaction: 0
Red spots (scattered reactions): 1
Moderate but confluent redness: 2
Redness and swelling: 3
Intense reddening and swelling: 4
The test sites were shaved with an electric razor after the first reading. All animals were killed at the
end of the test period by carbon dioxide asphyxiation. - Challenge controls:
- yes
- Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: This site was blue discoloured, which made skin reading difficult
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 4
- Total no. in group:
- 20
- Remarks on result:
- other: in some case the site was blue discoloured, which made skin reading difficult.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: in some case the site was blue discoloured, which made skin reading difficult.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 11
- Total no. in group:
- 20
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 8
- Total no. in group:
- 20
Any other information on results incl. tables
Preliminary Study
No signs of systemic toxicity were observed during the preliminary study.
However, body weight loss was noted in one of the five animals. Selection of the test substance concentrations used in the main study was based on the findings in the preliminary study and in accordance with Magnusson and Kligtnan (1969).
Main Study
Induction: the experimental animals showed no visual erythema or oedema after the 48 hours occluded epidermal induction exposure. The treated skin area of all animals was blue discoloured by the test substance.
Main Study Challenge
-Control Group: No skin reactions were evident after the challenge exposure, with the exception of red spots noted in response to the 10% test substance concentration in one animal. A few control animals showed blue discolouration of the treated skin sites exposed to the 25 % and 10 % concentrations.
-Experimental Group: Three, twelve and eight animals showed red spots in response to the 50 %, 25 % and 10 % test substance concentrations, respectively. The majority of experimental animals showed blue discolouration of the treated skin sites exposed to the 25 % and 10 % concentrations and a few animals al so on the treated skin sites exposed to the 50 % concentration.
Toxicity Symptoms / Mortality
No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study during the study period.
Body Weight
The average body weight gain of experimental and control animals was similar.
Applicant's summary and conclusion
- Interpretation of results:
- other: Classified according to the CLP Regulation (EC 1272/2008) Skin sens. Cat. 1A
- Conclusions:
- The substance has sensitising properties
- Executive summary:
The skin sensitisation potential was evaluated with an in vivo maximization test on guinea pigs, according to the method B.6 of EEC-Directive 92/69 EEC. A preliminary study was performed in order to determine the test concentrations of the main study. The concentrations 0, 10, 25 and 50 % were tested on 20 animals by intradermal (first induction) and the epidermal routes of administration (second induction and challenge). The readings after the challenge were at 24 and 48 hours. Three, twelve and eight animals showed positive reactions (redness score 1) to the 50%, 25% and 10% test substance concentrations, respectively. The majority of experimental animals showed blue discolouration of the treated skin sites exposed to the 25% and 10% concentrations and a few animals also on the treated skin sites exposed to the 50% concentration at 24-hour observation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.